Sanofi ditches mRNA COVID-19 vaccine amid rivals’ success – Reuters

PARIS, Sept 28 (Reuters) – Sanofi (SASY.PA) is dropping plans for its own mRNA-based COVID-19 vaccine because of the dominant role of the BioNTech-Pfizer (22UAy.DE)(PFE.N) alliance as well as Moderna… [read more]

Leave a Reply

Your email address will not be published. Required fields are marked *